1. Home
  2. KVHI vs KZIA Comparison

KVHI vs KZIA Comparison

Compare KVHI & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

SELL

Current Price

$6.62

Market Cap

133.0M

Sector

Technology

ML Signal

SELL

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$4.89

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVHI
KZIA
Founded
1978
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.0M
125.6M
IPO Year
1996
2002

Fundamental Metrics

Financial Performance
Metric
KVHI
KZIA
Price
$6.62
$4.89
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $27.60
AVG Volume (30 Days)
80.5K
★ 251.4K
Earning Date
11-05-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 33.33
N/A
EPS
★ 0.01
N/A
Revenue
★ $9,622,000.00
N/A
Revenue This Year
$27.78
N/A
Revenue Next Year
$36.03
N/A
P/E Ratio
$716.00
★ N/A
Revenue Growth
★ 3.82
N/A
52 Week Low
$5.76
$4.86
52 Week High
$13.00
$17.40

Technical Indicators

Market Signals
Indicator
KVHI
KZIA
Relative Strength Index (RSI) 41.26 23.06
Support Level $5.84 N/A
Resistance Level $7.86 $14.85
Average True Range (ATR) 0.54 0.69
MACD -0.04 -0.20
Stochastic Oscillator 33.12 4.69

Price Performance

Historical Comparison
KVHI
KZIA

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: